Hoppensteadt, D A <br/><br/>
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin.  [electronic resource] 

 -  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis  Jun 1995 
 - S57-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0957-5235 
<br/><br/><label>Standard No.: </label>10.1097/00001721-199506001-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Enoxaparin--pharmacology<br/>Factor Xa Inhibitors<br/>Heparin--pharmacology<br/>Heparin, Low-Molecular-Weight--pharmacology<br/>Humans<br/>Kinetics<br/>Lipoproteins--analysis<br/>Nadroparin--therapeutic use<br/>Placebos<br/>Thrombophlebitis--prevention & control